End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.85 USD | -0.51% |
|
-1.20% | -3.43% |
Jul. 03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
Jul. 03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
Official Publications
No official publication found
- Stock Market
- Equities
- JNJ Stock
- JNJD Stock
- News Johnson & Johnson
- Official Publications